Zhengye Biotechnology Holding Limited Deferred Income Tax Expense (Benefit)
Zhengye Biotechnology Holding Limited (ZYBT) reported Deferred Income Tax Expense (Benefit) of CNY 11.10 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-04-28
CNY
| Period end | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|
| 2025-12-31 | 11.10M CNY 20-F · filed 2026-04-28 | |
| 2025-06-30 | -5.34M CNY 6-K · filed 2025-12-12 | |
| 2024-12-31 | 924.00K CNY 20-F · filed 2026-04-28 | |
| 2024-06-30 | 1.24M CNY 6-K · filed 2025-12-12 | |
| 2023-12-31 | 541.00K CNY 20-F · filed 2026-04-28 | |
| 2022-12-31 | -1.31M CNY 20-F · filed 2025-07-03 |
USD
| Period end | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|
| 2025-12-31 | $1.59M 20-F · filed 2026-04-28 | |
| 2025-06-30 | -$745.00K 6-K · filed 2025-12-12 | |
| 2024-12-31 | $127.00K 20-F · filed 2025-07-03 |